Virion\Serion EPSTEIN-BARR VIRUS EBNA1 IgG BC1362G

The Virion-Serion EPSTEIN-BARR VIRUS EBNA1 IgG BC1362G is a quantitative ELISA test designed for the detection of IgG antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1) in human serum or plasma. This test provides accurate and precise results, aiding in the confirmation of previous EBV infection, distinguishing between acute and chronic infection, monitoring EBV infection in immunosuppressed patients, and assessing the response to EBV therapy.

Benefits/Advantages:

• Reliable Detection: The test offers reliable and sensitive detection of EBNA-1 antibodies in patient samples, providing valuable information for diagnosis and treatment decisions.

• Versatile Clinical Applications: It can be used in various clinical settings, including hospitals, laboratories, and research institutions, facilitating its widespread use.

• Long-lasting Antibody Detection: The test detects IgG antibodies to EBNA-1, which remain detectable for life, ensuring long-term diagnosis and monitoring possibilities.

• Aid in Treatment Monitoring: The test helps healthcare professionals assess the efficacy of EBV therapy and make informed decisions regarding treatment adjustments.